The aim of this study was to investigate possible differences in measures on disease process, joint damage, health status and self-efficacy between patients with rheumatoid arthritis (RA) living in an affluent and in a less affluent area in the same city. We analyzed data collected on patients enrolled in a community-based register of patients with RA in Oslo, Norway. 246 patients were examined by questionnaire in 1994 and 133 patients were examined clinically in 1997. Measures on disease process, joint damage, health status and self-efficacy were compared between patients from two residential areas. There was no significant difference regarding joint counts, patients' or investigator's evaluation of disease severity, blood test results and...
Objective. Few data have been presented to document the impact of rheumatoid arthritis (RA) on socio...
In this chapter, we discuss challenges in collecting data on outcomes of patients who receive usual ...
In this chapter, we discuss challenges in collecting data on outcomes of patients who receive usual ...
OBJECTIVE: Patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES) are known t...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
In this chapter, we discuss challenges in collecting data on outcomes of patients who receive usual ...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
Objective. Few data have been presented to document the impact of rheumatoid arthritis (RA) on socio...
In this chapter, we discuss challenges in collecting data on outcomes of patients who receive usual ...
In this chapter, we discuss challenges in collecting data on outcomes of patients who receive usual ...
OBJECTIVE: Patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES) are known t...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
In this chapter, we discuss challenges in collecting data on outcomes of patients who receive usual ...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
OBJECTIVES: To investigate the relationship of socioeconomic status (SES) on an individual and count...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
Objectives To investigate patterns in patient-reported and physician-reported disease outcomes in pa...
Objective. Few data have been presented to document the impact of rheumatoid arthritis (RA) on socio...
In this chapter, we discuss challenges in collecting data on outcomes of patients who receive usual ...
In this chapter, we discuss challenges in collecting data on outcomes of patients who receive usual ...